Relationship between the severity of hypokinesia induced by neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and neurochemical changes in brain structures of C57Bl/6 mice

[1]  E. Shin,et al.  3‐Hydroxymorphinan, a metabolite of dextromethorphan, protects nigrostriatal pathway against MPTP‐elicited damage both in vivo and in vitro , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[2]  Chun Luo,et al.  Enhanced De Novo Neurogenesis and Dopaminergic Neurogenesis in the Substantia Nigra of 1‐Methyl‐4‐phyenyl‐1,2,3,6‐Tetrahydropyridine‐Induced Parkinson's Disease‐Like Mice , 2006, Stem cells.

[3]  C. Cunha,et al.  Intra-nigral MPTP lesion in rats: Behavioral and autoradiography studies , 2005, Experimental Neurology.

[4]  Oleg Shupliakov,et al.  Evidence for neurogenesis in the adult mammalian substantia nigra , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[5]  M. Vila,et al.  The 1‐Methyl‐4‐Phenyl‐1,2,3,6‐Tetrahydropyridine Mouse Model , 2003 .

[6]  G. Miller,et al.  Detection of Behavioral Impairments Correlated to Neurochemical Deficits in Mice Treated with Moderate Doses of 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine , 2002, Experimental Neurology.

[7]  Joseph P Huston,et al.  Behavioral phenotyping of the MPTP mouse model of Parkinson's disease , 2001, Behavioural Brain Research.

[8]  R. Clavier,et al.  Effects of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and its metabolite, N-methyl-4-phenylpyridinium ion, on dopaminergic nigrostriatal neurons in the mouse , 1985, Neuroscience Letters.

[9]  R. Duvoisin,et al.  Dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine in mice. , 1984, Science.

[10]  G. Reynolds,et al.  Electrochemical detection of human brain transmitter amino acids by high-performance liquid chromatography of stable O-phthalaldehyde-sulphite derivatives , 2005, Journal of Neural Transmission / General Section JNT.

[11]  Y. Itoyama,et al.  Biochemical and immunohistological changes in the brain of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated mouse. , 2001, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.